spacer gif spacer gif spacer gif spacer gif spacer gif
QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geissen, M.
Right arrow Articles by Rohrer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geissen, M.
Right arrow Articles by Rohrer, H.

Development, Vol 125, Issue 23 4791-4801, Copyright © 1998 by Company of Biologists

JOURNAL ARTICLES

The specification of sympathetic neurotransmitter phenotype depends on gp130 cytokine receptor signaling

M Geissen, S Heller, D Pennica, U Ernsberger and H Rohrer
Max-Planck-Institut fur Hirnforschung, Abt. Neurochemie, Deutschordenstr. 46, Germany.

Sympathetic ganglia are composed of noradrenergic and cholinergic neurons. The differentiation of cholinergic sympathetic neurons is characterized by the expression of choline acetyltransferase (ChAT) and vasoactive intestinal peptide (VIP), induced in vitro by a subfamily of cytokines, including LIF, CNTF, GPA, OSM and cardiotrophin-1 (CT-1). To interfere with the function of these neuropoietic cytokines in vivo, antisense RNA for gp130, the common signal-transducing receptor subunit for neuropoietic cytokines, was expressed in chick sympathetic neurons, using retroviral vectors. A strong reduction in the number of VIP-expressing cells, but not of cells expressing ChAT or the adrenergic marker tyrosine hydroxylase (TH), was observed. These results reveal a physiological role of neuropoietic cytokines for the control of VIP expression during the development of cholinergic sympathetic neurons.


This article has been cited by other articles:


Home page
 DevelopmentHome page
M. Stanke, C. V. Duong, M. Pape, M. Geissen, G. Burbach, T. Deller, H. Gascan, R. Parlato, G. Schutz, and H. Rohrer
Target-dependent specification of the neurotransmitter phenotype: cholinergic differentiation of sympathetic neurons is mediated in vivo by gp130 signaling
Development, January 1, 2006; 133(1): 141 - 150.
[Abstract] [Full Text] [PDF]

Home page
 DevelopmentHome page
F. Muller and H. Rohrer
Molecular control of ciliary neuron development: BMPs and downstream transcriptional control in the parasympathetic lineage
Development, March 14, 2003; 129(24): 5707 - 5717.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
S. I. Savitz and J. A. Kessler
Leukemia Inhibitory Factor Requires Concurrent p75LNTR Signaling to Induce Apoptosis of Cultured Sympathetic Neurons
J. Neurosci., June 1, 2000; 20(11): 4198 - 4205.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
R. L. Moritz, N. E. Hall, L. M. Connolly, and R. J. Simpson
Determination of the Disulfide Structure and N-Glycosylation Sites of the Extracellular Domain of the Human Signal Transducer gp130
J. Biol. Chem., March 9, 2001; 276(11): 8244 - 8253.
[Abstract] [Full Text] [PDF]


© The Company of Biologists Ltd 1998